{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:31:22Z","timestamp":1792027882533,"version":"4.4.0"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"14","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"Italian Ministry of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,15]]},"DOI":"10.1093\/hmg\/ddy153","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T06:40:17Z","timestamp":1524465617000},"page":"2490-2501","source":"Crossref","is-referenced-by-count":43,"title":["Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood\u2013brain barrier integrity and exerts therapeutic effect in an animal model of Huntington\u2019s disease"],"prefix":"10.1093","volume":"27","author":[{"given":"Alba","family":"Di Pardo","sequence":"first","affiliation":[{"name":"IRCCS Neuromed, Localit\u00e1 Camerelle, Pozzilli (IS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Castaldo","sequence":"additional","affiliation":[{"name":"IRCCS Neuromed, Localit\u00e1 Camerelle, Pozzilli (IS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Amico","sequence":"additional","affiliation":[{"name":"IRCCS Neuromed, Localit\u00e1 Camerelle, Pozzilli (IS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pepe","sequence":"additional","affiliation":[{"name":"IRCCS Neuromed, Localit\u00e1 Camerelle, Pozzilli (IS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Marracino","sequence":"additional","affiliation":[{"name":"IRCCS Neuromed, Localit\u00e1 Camerelle, Pozzilli (IS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Capocci","sequence":"additional","affiliation":[{"name":"IRCCS Neuromed, Localit\u00e1 Camerelle, Pozzilli (IS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Giovannelli","sequence":"additional","affiliation":[{"name":"IRCCS Neuromed, Localit\u00e1 Camerelle, Pozzilli (IS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Madonna","sequence":"additional","affiliation":[{"name":"IRCCS Neuromed, Localit\u00e1 Camerelle, Pozzilli (IS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"van Bergeijk","sequence":"additional","affiliation":[{"name":"AbbVie Deutschland GmbH & Co KG, Knollstrasse 50, Ludwigshafen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Buttari","sequence":"additional","affiliation":[{"name":"IRCCS Neuromed, Localit\u00e1 Camerelle, Pozzilli (IS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"van der Kam","sequence":"additional","affiliation":[{"name":"AbbVie Deutschland GmbH & Co KG, Knollstrasse 50, Ludwigshafen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Maglione","sequence":"additional","affiliation":[{"name":"IRCCS Neuromed, Localit\u00e1 Camerelle, Pozzilli (IS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"key":"key\n\t\t\t\t20180703035758_ddy153-B1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-971176","article-title":"Huntington\u2019s disease","volume":"27","author":"Walker","year":"2007","journal-title":"Semin. Neurol"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mad.2005.09.011","article-title":"Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington\u2019s disease mutation","volume":"127","author":"Maglione","year":"2006","journal-title":"Mech. Ageing Dev"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2005.09.037","article-title":"The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington\u2019s disease patients with predominant chorea","volume":"393","author":"Maglione","year":"2006","journal-title":"Neurosci. Lett"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B5","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1523\/JNEUROSCI.6348-09.2010","article-title":"Impaired ganglioside metabolism in Huntington\u2019s disease and neuroprotective role of GM1","volume":"30","author":"Maglione","year":"2010","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B6","doi-asserted-by":"crossref","first-page":"457.","DOI":"10.3389\/fnins.2016.00457","article-title":"Impaired levels of gangliosides in the corpus callosum of Huntington disease animal models","volume":"10","author":"Di Pardo","year":"2016","journal-title":"Front. Neurosci"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B7","doi-asserted-by":"crossref","first-page":"5280.","DOI":"10.1038\/s41598-017-05709-y","article-title":"Defective sphingosine-1-phosphate metabolism is a druggable target in Huntington\u2019s disease","volume":"7","author":"Di Pardo","year":"2017","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B8","doi-asserted-by":"crossref","first-page":"43030.","DOI":"10.1038\/srep43030","article-title":"Metabolic profiling of presymptomatic Huntington\u2019s disease sheep reveals novel biomarkers","volume":"7","author":"Skene","year":"2017","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B9","doi-asserted-by":"crossref","first-page":"15213.","DOI":"10.1038\/srep15213","article-title":"Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy","volume":"5","author":"Moruno Manchon","year":"2015","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nmeth.3940","article-title":"Revealing disease-associated pathways by network integration of untargeted metabolomics","volume":"13","author":"Pirhaji","year":"2016","journal-title":"Nat. Methods"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B11","doi-asserted-by":"crossref","first-page":"623.","DOI":"10.1038\/s41467-017-00353-6","article-title":"Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements","volume":"8","author":"Pirhaji","year":"2017","journal-title":"Nat. Commun"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B12","doi-asserted-by":"crossref","first-page":"698.","DOI":"10.3389\/fnins.2017.00698","article-title":"De novo synthesis of sphingolipids is defective in experimental models of Huntington\u2019s disease","volume":"11","author":"Di Pardo","year":"2017","journal-title":"Front. Neurosci"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pharmthera.2007.08.005","article-title":"Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis","volume":"117","author":"Dev","year":"2008","journal-title":"Pharmacol. Ther"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B14","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1523\/JNEUROSCI.4645-04.2005","article-title":"Edg8\/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival","volume":"25","author":"Jaillard","year":"2005","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B15","doi-asserted-by":"crossref","first-page":"133.","DOI":"10.1186\/1742-2094-9-133","article-title":"Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier","volume":"9","author":"van Doorn","year":"2012","journal-title":"J. Neuroinflam"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1755-5949.2012.00340.x","article-title":"Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances","volume":"18","author":"Liu","year":"2012","journal-title":"CNS Neurosci. Ther"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet","year":"2015","journal-title":"Ann. Neurol"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B18","doi-asserted-by":"crossref","first-page":"41316.","DOI":"10.1038\/srep41316","article-title":"Impairment of blood-brain barrier is an early event in R6\/2 mouse model of Huntington Disease","volume":"7","author":"Di Pardo","year":"2017","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuropharm.2016.11.006","article-title":"Sphingosine-1-phosphate receptor therapies: advances in clinical trials for CNS-related diseases","volume":"113","author":"O\u2019Sullivan","year":"2017","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B20","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1073\/pnas.1401595111","article-title":"Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice","volume":"111","author":"Winkler","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B21","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","article-title":"FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease","volume":"23","author":"Di Pardo","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B22","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1093\/hmg\/ddv218","article-title":"Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington\u2019s disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation","volume":"24","author":"Miguez","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B23","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1021\/acs.jmedchem.5b00928","article-title":"Discovery of A-971432, an orally bioavailable selective sphingosine-1-phosphate receptor 5 (s1p5) agonist for the potential treatment of neurodegenerative disorders","volume":"58","author":"Hobson","year":"2015","journal-title":"J. Med. Chem"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ana.25007","article-title":"Body weight is a robust predictor of clinical progression in Huntington disease","volume":"82","author":"van der Burg","year":"2017","journal-title":"Ann. Neurol"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1148\/radiol.2523081426","article-title":"Carotid artery brain aneurysm model: in vivo molecular enzyme-specific MR imaging of active inflammation in a pilot study","volume":"252","author":"DeLeo","year":"2009","journal-title":"Radiology"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B26","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/hmg\/ddx046","article-title":"Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease","volume":"26","author":"Moruno-Manchon","year":"2017","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B27","first-page":"2179","article-title":"Transgenic animal models for study of the pathogenesis of Huntington\u2019s disease and therapy","volume":"9","author":"Chang","year":"2015","journal-title":"Drug Des. Devel. Ther"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B28","doi-asserted-by":"crossref","first-page":"1307.","DOI":"10.1038\/s41598-017-01510-z","article-title":"The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients","volume":"7","author":"Neueder","year":"2017","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B30","doi-asserted-by":"crossref","first-page":"422.","DOI":"10.1016\/S0962-8924(97)88136-6","article-title":"Nuclear inclusions in Huntington\u2019s disease","volume":"7","author":"Davies","year":"1997","journal-title":"Trends Cell Biol"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B31","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","article-title":"Huntington disease models and human neuropathology: similarities and differences","volume":"115","author":"Vonsattel","year":"2007","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2007.04.006","article-title":"Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology","volume":"115","author":"Brinkmann","year":"2007","journal-title":"Pharmacol. Ther"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/ddi443","article-title":"Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1\/2 protects against mutant huntingtin-associated toxicity","volume":"15","author":"Apostol","year":"2006","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B35","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1460-9568.2005.03985.x","article-title":"Akt is altered in an animal model of Huntington\u2019s disease and in patients","volume":"21","author":"Colin","year":"2005","journal-title":"Eur. J. Neurosci"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B36","doi-asserted-by":"crossref","first-page":"37445","DOI":"10.1074\/jbc.M110.125542","article-title":"Mutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathway","volume":"285","author":"Varma","year":"2010","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington\u2019s disease and involves Huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Dev. Cell"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/bies.201100116","article-title":"A novel target for Huntington\u2019s disease: eRK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington\u2019s disease and its upregulation ameliorates pathology","volume":"34","author":"Bodai","year":"2012","journal-title":"Bioessays"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/JHD-120033","article-title":"Pizotifen activates ERK and provides neuroprotection in vitro and in vivo in models of Huntington\u2019s disease","volume":"1","author":"Sarantos","year":"2012","journal-title":"J. Huntingtons Dis"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.14336\/AD.2015.0825","article-title":"The involvement of BDNF, NGF and GDNF in aging and Alzheimer\u2019s disease","volume":"6","author":"Budni","year":"2015","journal-title":"Aging Dis"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B41","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"11","author":"Bathina","year":"2015","journal-title":"Arch. Med. Sci"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08977190410001723308","article-title":"Brain-derived neurotrophic factor","volume":"22","author":"Binder","year":"2004","journal-title":"Growth Factors"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B44","doi-asserted-by":"crossref","first-page":"e64037.","DOI":"10.1371\/journal.pone.0064037","article-title":"Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6\/2 mouse model of Huntington\u2019s disease","volume":"8","author":"Giampa","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B45","doi-asserted-by":"crossref","first-page":"71.","DOI":"10.1186\/1750-1326-6-71","article-title":"Conditional BDNF release under pathological conditions improves Huntington\u2019s disease pathology by delaying neuronal dysfunction","volume":"6","author":"Giralt","year":"2011","journal-title":"Mol. Neurodegener"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B46","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1073\/pnas.1206093109","article-title":"Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome","volume":"109","author":"Deogracias","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B47","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s11064-016-2125-4","article-title":"FTY720 attenuates 6-OHDA-associated dopaminergic degeneration in cellular and mouse Parkinsonian models","volume":"42","author":"Ren","year":"2017","journal-title":"Neurochem. Res"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B48","doi-asserted-by":"crossref","first-page":"e81547.","DOI":"10.1371\/journal.pone.0081547","article-title":"In vivo regulation of brain-derived neurotrophic factor in dorsal root ganglia is mediated by nerve growth factor-triggered Akt activation during cystitis","volume":"8","author":"Qiao","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2015.12.057","article-title":"Amitriptyline induces brain-derived neurotrophic factor (BDNF) mRNA expression through ERK-dependent modulation of multiple BDNF mRNA variants in primary cultured rat cortical astrocytes and microglia","volume":"1634","author":"Hisaoka-Nakashima","year":"2016","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2007.04.026","article-title":"Interaction of FGF-2 with IGF-1 and BDNF in stimulating Akt, ERK, and neuronal survival in hippocampal cultures","volume":"1154","author":"Johnson-Farley","year":"2007","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B51","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders","volume":"421","author":"Sanchez","year":"2003","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B53","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.addr.2005.01.009","article-title":"Occludin: structure, function and regulation","volume":"57","author":"Feldman","year":"2005","journal-title":"Adv. Drug Deliv. Rev"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B54","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1096\/fj.07-8319com","article-title":"Formation of tight junction: determinants of homophilic interaction between classic claudins","volume":"22","author":"Piontek","year":"2008","journal-title":"Faseb J"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10571-006-9028-x","article-title":"Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5","volume":"26","author":"Honda","year":"2006","journal-title":"Cell Mol. Neurobiol"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B56","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1242\/jcs.109.9.2287","article-title":"Occludin is a functional component of the tight junction","volume":"109 (Pt 9)","author":"McCarthy","year":"1996","journal-title":"J. Cell Sci"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B57","doi-asserted-by":"crossref","first-page":"e12967.","DOI":"10.1111\/nmo.12967","article-title":"BDNF modulates intestinal barrier integrity through regulating the expression of tight junction proteins","volume":"29","author":"Yu","year":"2017","journal-title":"Neurogastroenterol. Motil"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B58","doi-asserted-by":"crossref","DOI":"10.33549\/physiolres.933641","article-title":"Brain-derived neurotrophic factor modulates intestinal barrier by inhibiting intestinal epithelial cells apoptosis in mice","author":"Zhao","year":"2018","journal-title":"Physiol. Res"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B59","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nm.4331","article-title":"Pericytes impair capillary blood flow and motor function after chronic spinal cord injury","volume":"23","author":"Li","year":"2017","journal-title":"Nat. Med"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B60","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmed.2015.03.006","article-title":"Sphingosine 1-phosphate signaling at the blood-brain barrier","volume":"21","author":"Prager","year":"2015","journal-title":"Trends Mol. Med"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B61","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4062\/biomolther.2016.160","article-title":"Sphingosine 1-phosphate receptor modulators and drug discovery","volume":"25","author":"Park","year":"2017","journal-title":"Biomol. Ther"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B62","doi-asserted-by":"crossref","first-page":"109","DOI":"10.12703\/P6-109","article-title":"S1P signaling: new therapies and opportunities","volume":"6","author":"Gonzalez-Cabrera","year":"2014","journal-title":"F1000Prime Rep"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/mol.105.020552","article-title":"Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1, 3-propanediol, interact with the CB1 cannabinoid receptor","volume":"70","author":"Paugh","year":"2006","journal-title":"Mol. Pharmacol"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B64","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jnc.14098","article-title":"Endocannabinoid system in neurodegenerative disorders","volume":"142","author":"Basavarajappa","year":"2017","journal-title":"J. Neurochem"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B65","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/hmg\/ddw050","article-title":"Motor deficits associated with Huntington\u2019s disease occur in the absence of striatal degeneration in BACHD transgenic mice","volume":"25","author":"Mantovani","year":"2016","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B66","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2011.09.003","article-title":"Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease","volume":"45","author":"Franciosi","year":"2012","journal-title":"Neurobiol. Dis"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B67","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1073\/pnas.1114502109","article-title":"Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice","volume":"109","author":"Di Pardo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B68","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.4161\/cc.28401","article-title":"Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events","volume":"13","author":"McCloy","year":"2014","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20180703035758_ddy153-B69","doi-asserted-by":"crossref","first-page":"12564","DOI":"10.1073\/pnas.0914191107","article-title":"Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2\/PP2A balance","volume":"107","author":"Burgess","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/27\/14\/2490\/25098870\/ddy153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T17:40:46Z","timestamp":1661017246000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/27\/14\/2490\/4983968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":69,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2018,4,24]]},"published-print":{"date-parts":[[2018,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddy153","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7,15]]},"published":{"date-parts":[[2018,4,24]]}}}